Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

0.3769 -0.0130 (-3.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 355,881
Open 0.3899
Bid (Size) 0.3700 (1)
Ask (Size) 0.4392 (1)
Prev. Close 0.3899
Today's Range 0.3737 - 0.3899
52wk Range 0.3550 - 4.080
Shares Outstanding 42,688,246
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Harvard Bioscience Announces CFO Transition
From Harvard Bioscience, Inc.
Via GlobeNewswire
Traders are paying attention to the gapping stocks in Tuesday's session.
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill

Performance

YTD
-81.4%
-81.4%
1 Month
-38.2%
-38.2%
3 Month
-79.1%
-79.1%
6 Month
-84.4%
-84.4%
1 Year
-89.8%
-89.8%

More News

Read More
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Earnings Scheduled For March 12, 2025
Via Benzinga
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Harvard Bioscience Announces Third Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting
From Harvard Bioscience, Inc.
Via GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024
Via InvestorPlace
Harvard Bioscience Announces Second Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Holley And 2 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Harvard Bioscience Announces First Quarter 2024 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
From Harvard Bioscience, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Harvard Bioscience, Inc. - Common Stock publicly traded?
Yes, Harvard Bioscience, Inc. - Common Stock is publicly traded.
What exchange does Harvard Bioscience, Inc. - Common Stock trade on?
Harvard Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harvard Bioscience, Inc. - Common Stock?
The ticker symbol for Harvard Bioscience, Inc. - Common Stock is HBIO on the Nasdaq Stock Market
What is the current price of Harvard Bioscience, Inc. - Common Stock?
The current price of Harvard Bioscience, Inc. - Common Stock is 0.3769
When was Harvard Bioscience, Inc. - Common Stock last traded?
The last trade of Harvard Bioscience, Inc. - Common Stock was at 04/25/25 04:00 PM ET
What is the market capitalization of Harvard Bioscience, Inc. - Common Stock?
The market capitalization of Harvard Bioscience, Inc. - Common Stock is 16.09M
How many shares of Harvard Bioscience, Inc. - Common Stock are outstanding?
Harvard Bioscience, Inc. - Common Stock has 16M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.